Inge C Gyssens Selected Research

Ceftizoxime (Cefizox)

10/2007	Effect of dosing and dosing frequency on the efficacy of ceftizoxime and the emergence of ceftizoxime resistance during the early development of murine abscesses caused by Bacteroides fragilis and Enterobacter cloacae mixed infection.
5/2004	Comparative study of the effects of ceftizoxime, piperacillin, and piperacillin-tazobactam concentrations on antibacterial activity and selection of antibiotic-resistant mutants of Enterobacter cloacae and Bacteroides fragilis in vitro and in vivo in mixed-infection abscesses.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Inge C Gyssens Research Topics

Disease

15	Infections 03/2022 - 03/2002
6	Abscess 02/2020 - 03/2002
5	Coinfection 10/2007 - 03/2002
4	Communicable Diseases (Infectious Diseases) 09/2018 - 08/2014
3	Inflammation (Inflammations) 03/2022 - 08/2014
3	Porcine Reproductive and Respiratory Syndrome (PRRS) 01/2015 - 12/2012
2	Bacterial Infections (Bacterial Infection) 03/2022 - 08/2014
2	Sepsis (Septicemia) 03/2022 - 09/2021
2	Appendicitis 01/2022 - 10/2020
2	Pneumonia (Pneumonitis) 09/2021 - 09/2005
2	Respiratory Tract Infections (Respiratory Tract Infection) 01/2018 - 08/2014
2	Leukemia 12/2013 - 12/2013
2	Surgical Wound Infection 04/2007 - 12/2006
2	Wounds and Injuries (Trauma) 12/2006 - 01/2002
2	Acquired Immunodeficiency Syndrome (AIDS) 10/2003 - 07/2002
1	Virus Diseases (Viral Diseases) 03/2022
1	COVID-19 05/2021
1	Hypertension (High Blood Pressure) 05/2021
1	Diabetic Foot 02/2020
1	Hypersensitivity (Allergy) 01/2018
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 07/2017
1	Melanoma (Melanoma, Malignant) 01/2015
1	Reinfection 08/2014
1	Mycoses (Diseases, Fungus) 08/2014
1	Disease Progression 12/2013
1	Fever of Unknown Origin 12/2013
1	Febrile Neutropenia 12/2013
1	Neutropenia 12/2013
1	Blister (Bulla) 07/2010
1	Urinary Tract Infections (Urinary Tract Infection) 02/2003
1	Crystalluria 02/2003
1	Body Weight (Weight, Body) 12/2002
1	Hematuria 08/2002
1	Nephrolithiasis 07/2002
1	Renal Colic 07/2002
1	Renal Insufficiency (Renal Failure) 07/2002
1	Abdominal Abscess 03/2002

Drug/Important Bio-Agent (IBA)

11	Anti-Bacterial Agents (Antibiotics)IBA 09/2021 - 12/2002
4	Pattern Recognition ReceptorsIBA 10/2020 - 12/2012
3	Biomarkers (Surrogate Marker)IBA 03/2022 - 10/2020
3	CytokinesIBA 10/2020 - 01/2003
3	Toll-Like Receptors (Toll-Like Receptor)IBA 02/2020 - 01/2015
2	Carbapenems (Carbapenem Antibiotics)IBA 01/2021 - 01/2020
2	Interleukin-6 (Interleukin 6)IBA 10/2020 - 01/2003
2	Interleukin-8 (Interleukin 8)IBA 10/2020 - 01/2003
2	Pharmaceutical PreparationsIBA 01/2020 - 09/2018
2	Moxifloxacin (Avelox)FDA Link 11/2011 - 09/2005
2	Tazobactam Drug Combination Piperacillin (Zosyn)FDA LinkGeneric 11/2011 - 05/2004
2	Ceftizoxime (Cefizox)FDA Link 10/2007 - 05/2004
2	CreatinineIBA 02/2003 - 08/2002
2	Indinavir (Crixivan)FDA Link 02/2003 - 07/2002
2	AlbuminsIBA 02/2003 - 08/2002
1	Proteins (Proteins, Gene)FDA Link 03/2022
1	C-Reactive ProteinIBA 01/2022
1	Cathepsin BIBA 01/2022
1	tocilizumab (atlizumab)FDA Link 09/2021
1	SteroidsIBA 09/2021
1	Ferritins (Ferritin)IBA 05/2021
1	Interleukin-10 (Interleukin 10)IBA 10/2020
1	LigandsIBA 10/2020
1	carbapenemaseIBA 01/2020
1	Colistin (Coly-Mycin)FDA Link 01/2020
1	Retinoic Acid Receptors (Retinoic Acid Receptor)IBA 01/2015
1	NucleotidesIBA 01/2015
1	Pathogen-Associated Molecular Pattern MoleculesIBA 01/2015
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2015
1	C-Type Lectins (C-Type Lectin)IBA 01/2015
1	Interleukin-22 (IL-22)IBA 08/2014
1	Interleukin-17 (Interleukin 17)IBA 08/2014
1	Tigecycline (Tygacil)FDA Link 12/2013
1	Fosfomycin FDA Link 12/2013
1	Clavulanic Acid (Potassium Clavulanate)FDA LinkGeneric 11/2011
1	Amoxicillin (Wymox)FDA LinkGeneric 11/2011
1	FluoroquinolonesIBA 09/2005
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 09/2005
1	trovafloxacinIBA 09/2005
1	Piperacillin FDA LinkGeneric 05/2004
1	Tazobactam FDA LinkGeneric 05/2004
1	Cephalosporins (Cephalosporin Antibiotics)IBA 05/2004
1	Serum AlbuminIBA 02/2003
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2003
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2003
1	Imipenem FDA Link 12/2002
1	Drug CarriersIBA 03/2002
1	Gold Colloid (Colloidal Gold)IBA 03/2002
1	Capsules (Microcapsules)IBA 03/2002
1	Liposomes (Liposome)IBA 03/2002

Therapy/Procedure

10	Therapeutics 09/2021 - 07/2002
2	Length of Stay 10/2016 - 12/2006
2	Immunomodulation 08/2014 - 09/2005
2	Antibiotic Prophylaxis 04/2007 - 12/2006
1	Kidney Transplantation 07/2017
1	Hip Replacement Arthroplasty (Total Hip Replacement) 04/2007
1	Highly Active Antiretroviral Therapy (HAART) 10/2003
1	Liver Transplantation 01/2003
1	Punctures 12/2002
1	Debridement 01/2002